PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT05340270 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05340270
- Sponsor
- Guangxi Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2026-03-29
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.